Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00263731
Official study title

Metabolomic Analysis of Lung Cancer

Study summary

The purpose of this study is to learn more about the metabolic properties of lung cancer cells.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studied13-C-glucose

The study team can explain what participation involves.

Who it may be forNon-small cell lung cancer (NSCLC) · Small cell lung cancer (SCLC)

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 9, 2022 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of Louisville

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
University of Louisville
Interventions being studied
Other: 13-C-glucose
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Cancer type
Non-small cell lung cancer (NSCLC)→Small cell lung cancer (SCLC)→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Lung Cancer Patients (Groups 1 \& 2)
  • patients with suspected, clinically diagnosed, or histologically diagnosed lung cancer. Occasionally, other cancers (including metastatic cancers to the lung) may be resected for the study as negative controls for NSCLC, as warranted by the particulars of the case.
  • patients must have general medical conditions to allow them to undergo surgical resection of their primary tumor
Reasons someone may not be able to joinExclusion criteria
  • history of diabetes for the experimental group (surgery + glucose); patients with a history of diabetes are allowed in the control group (surgery/no glucose)
  • known hepatitis C or HIV (AIDS) Healthy Subjects (Group 3) Inclusion Criteria:
  • at least 30 years of age
  • preferably be fasting for 12 hours (minimum 8 hours) prior to enrollment

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • James Graham Brown Cancer Center, University of LouisvilleLouisville, Kentucky

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 9, 2022. Always confirm current availability with the study team.

View original record ↗